The CD20 homolog Ms4a8a integrates pro- and anti-inflammatory signals in novel M2-like macrophages and is expressed in parasite infection

European Journal of Immunology

Volumn 42, Issue 11, 2012, Pages 2971-2982

  Schmieder, Astrid ^a   Schledzewski, Kai ^a   Michel, Julia ^a   Schönhaar, Kathrin ^a   Morias, Yannick ^b,c   Bosschaerts, Tom ^b,c   Van den Bossche, Jan ^b,c   Dorny, Pierre ^d   Sauer, Andrea ^a   Sticht, Carsten ^e   Géraud, Cyrill ^a   Waibler, Zoe ^f   Beschin, Alain ^b,c   Goerdt, Sergij ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^d INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f PAUL EHRLICH INSTITUT   (Germany)

Author keywords

Alternative macrophage activation; CD20 homolog; Parasitic infection; Toll like receptor

Indexed keywords

ARGINASE 1; CD163 ANTIGEN; CELL PROTEIN; DEXAMETHASONE; GLUCOCORTICOID; IMIQUIMOD; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; MANNOSE RECEPTOR; MESSENGER RNA; MS4A8A PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; UNCLASSIFIED DRUG;

ARTICLE; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; INNATE IMMUNITY; LIVER; MACROPHAGE; NAGANA; PERITONEUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TAENIA CRASSICEPS; TAENIASIS; TRYPANOSOMA CONGOLENSE; UPREGULATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD20; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ARGINASE; CELL LINE; IMMUNITY, INNATE; LECTINS, C-TYPE; MACROPHAGE ACTIVATION; MACROPHAGES; MANNOSE-BINDING LECTINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; SIGNAL TRANSDUCTION; SPECIFIC PATHOGEN-FREE ORGANISMS; TAENIA; TAENIASIS; TOLL-LIKE RECEPTORS; TRYPANOSOMA CONGOLENSE; TRYPANOSOMIASIS, AFRICAN;

EID: 84868117572     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201142331     Document Type: Article

References (41)

1. Galli, S. J., Borregaard, N. and Wynn, T. A., Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat. Immunol. 2011. 12: 1035-1044.
2. Goerdt, S. and Orfanos, C. E., Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 1999. 10: 137-142.
3. Gordon, S., Alternative activation of macrophages. Nat. Rev. Immunol. 2003. 3: 23-35.
4. Martinez, F. O., Sica, A., Mantovani, A. and Locati, M., Macrophage activation and polarization. Front Biosci. 2008. 13: 453-461.
5. Raes, G., Beschin, A., Ghassabeh, G. H. and De Baetselier, P., Alternatively activated macrophages in protozoan infections. Curr. Opin. Immunol. 2007. 19: 454-459.
6. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A. and Locati, M., The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004. 25: 677-686.
7. Kurowska-Stolarska, M., Stolarski, B., Kewin, P., Murphy, G., Corrigan, C. J., Ying, S., Pitman, N. et al., IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J. Immunol. 2009. 183: 6469-6477.
8. Mosser, D. M. and Edwards, J. P., Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008. 8: 958-969.
9. Schmieder, A., Schledzewski, K., Michel, J., Tuckermann, J. P., Tome, L., Sticht, C., Gkaniatsou, C. et al., Synergistic activation by p38MAPK and glucocorticoid signaling mediates induction of M2-like tumor-associated macrophages expressing the novel CD20 homolog MS4A8A. Int. J. Cancer 2011. 129: 122-132.
10. Anthony, R. M., Urban, J. F., Jr., Alem, F., Hamed, H. A., Rozo, C. T., Boucher, J. L., Van Rooijen, N. et al., Memory T(H)2 cells induce alternatively activated macrophages to mediate protection against nematode parasites. Nat. Med. 2006. 12: 955-960.
11. Jenkins, S. J. and Allen, J. E., Similarity and diversity in macrophage activation by nematodes, trematodes, and cestodes. J. Biomed. Biotechnol. 2010. 2010: 262609.
12. Noel, W., Hassanzadeh, G., Raes, G., Namangala, B., Daems, I., Brys, L., Brombacher, F. et al., Infection stage-dependent modulation of macrophage activation in Trypanosoma congolense-resistant and -susceptible mice. Infect. Immun. 2002. 70: 6180-6187.
13. Van den Bossche, J., Bogaert, P., van Hengel, J., Guerin, C. J., Berx, G., Movahedi, K., Van den Bergh, R. et al., Alternatively activated macrophages engage in homotypic and heterotypic interactions through IL-4 and polyamine-induced E-cadherin/catenin complexes. Blood 2009. 114: 4664-4674.
14. Varin, A. and Gordon, S., Alternative activation of macrophages: immune function and cellular biology. Immunobiology 2009. 214: 630-641.
15. Rodriguez-Sosa, M., Satoskar, A. R., Calderon, R., Gomez-Garcia, L., Saavedra, R., Bojalil, R. and Terrazas, L. I., Chronic helminth infection induces alternatively activated macrophages expressing high levels of CCR5 with low interleukin-12 production and Th2-biasing ability. Infect. Immun. 2002. 70: 3656-3664.
16. Drennan, M. B., Stijlemans, B., Van den Abbeele, J., Quesniaux, V. J., Barkhuizen, M., Brombacher, F., De Baetselier, P. et al., The induction of a type 1 immune response following a Trypanosoma brucei infection is MyD88 dependent. J. Immunol. 2005. 175: 2501-2509.
17. Guilliams, M., Movahedi, K., Bosschaerts, T., VandenDriessche, T., Chuah, M. K., Herin, M., Acosta-Sanchez, A. et al., IL-10 dampens TNF/inducible nitric oxide synthase-producing dendritic cell-mediated pathogenicity during parasitic infection. J. Immunol. 2009. 182: 1107-1118.
18. Harris, T. H., Mansfield, J. M. and Paulnock, D. M., CpG oligodeoxynucleotide treatment enhances innate resistance and acquired immunity to African trypanosomes. Infect. Immun. 2007. 75: 2366-2373.
19. Reyes, J. L., Gonzalez, M. I., Ledesma-Soto, Y., Satoskar, A. R. and Terrazas, L. I., TLR2 mediates immunity to experimental cysticercosis. Int. J. Biol. Sci. 2011. 7: 1323-1333.
20. Rodrigues, M. M., Oliveira, A. C. and Bellio, M., The immune response to Trypanosoma cruzi: role of Toll-like receptors and perspectives for vaccine development. J. Parasitol. Res. 2012. 2012: 507874.
21. Movahedi, K., Laoui, D., Gysemans, C., Baeten, M., Stange, G., Van den Bossche, J., Mack, M. et al., Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res. 2010. 70: 5728-5739.
22. Van Ginderachter, J. A., Movahedi, K., Van den Bossche, J. and De Baetselier, P., Macrophages, PPARs, and cancer. PPAR Res. 2008. 2008: 169414.
23. Kzhyshkowska, J., Gratchev, A. and Goerdt, S., Stabilin-1, a homeostatic scavenger receptor with multiple functions. J. Cell. Mol. Med. 2006. 10: 635-649.
24. + macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesis. J. Pathol. 2006. 209: 67-77.
25. Takeuch, O. and Akira, S., Epigenetic control of macrophage polarization. Eur. J. Immunol. 2011. 41: 2490-2493.
26. Howie, D., Nolan, K. F., Daley, S., Butterfield, E., Adams, E., Garcia-Rueda, H., Thompson, C. et al., MS4A4B is a GITR-associated membrane adapter, expressed by regulatory T cells, which modulates T cell activation. J. Immunol. 2009. 183: 4197-4204.
27. Rehli, M., Sulzbacher, S., Pape, S., Ravasi, T., Wells, C. A., Heinz, S., Sollner, L. et al., Transcription factor Tfec contributes to the IL-4-inducible expression of a small group of genes in mouse macrophages including the granulocyte colony-stimulating factor receptor. J. Immunol. 2005. 174: 7111-7122.
28. Deneault, E., Cellot, S., Faubert, A., Laverdure, J. P., Frechette, M., Chagraoui, J., Mayotte, N. et al., A functional screen to identify novel effectors of hematopoietic stem cell activity. Cell 2009. 137: 369-379.
29. Kim, H. J., Zou, W., Ito, Y., Kim, S. Y., Chappel, J., Ross, F. P. and Teitelbaum, S. L., Src-like adaptor protein regulates osteoclast generation and survival. J. Cell. Biochem. 2010. 110: 201-209.
30. Khan, M. M., Keaney, K. M., Melmon, K. L., Clayberger, C. and Krensky, A. M., Histamine regulates the generation of human cytolytic T lymphocytes. Cell. Immunol. 1989. 121: 60-73.
31. Khan, M. M., Sansoni, P., Engleman, E. G. and Melmon, K. L., Pharmacologic effects of autacoids on subsets of T cells. Regulation of expression/function of histamine-2 receptors by a subset of suppressor cells. J. Clin. Invest. 1985. 75: 1578-1583.
32. Jutel, M., Akdis, M. and Akdis, C. A., Histamine, histamine receptors and their role in immune pathology. Clin. Exp. Allergy 2009. 39: 1786-1800.
33. Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M. et al., A Toll-like receptor recognizes bacterial DNA. Nature 2000. 408: 740-745.
34. Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K. et al., Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 1999. 162: 3749-3752.
35. Hoebe, K., Du, X., Georgel, P., Janssen, E., Tabeta, K., Kim, S. O., Goode, J. et al., Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 2003. 424: 743-748.
36. Waibler, Z., Anzaghe, M., Ludwig, H., Akira, S., Weiss, S., Sutter, G. and Kalinke, U., Modified vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responses. J. Virol. 2007. 81: 12102-12110.
37. Reichardt, H. M., Kaestner, K. H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P. et al., DNA binding of the glucocorticoid receptor is not essential for survival. Cell 1998. 93: 531-541.
38. Namangala, B., De Baetselier, P., Noel, W., Brys, L. and Beschin, A., Alternative versus classical macrophage activation during experimental African trypanosomosis. J. Leukoc. Biol. 2001. 69: 387-396.
39. Bosschaerts, T., Guilliams, M., Noel, W., Herin, M., Burk, R. F., Hill, K. E., Brys, L. et al., Alternatively activated myeloid cells limit pathogenicity associated with African trypanosomiasis through the IL-10 inducible gene selenoprotein P. J. Immunol. 2008. 180: 6168-6175.
40. Brys, L., Beschin, A., Raes, G., Ghassabeh, G. H., Noel, W., Brandt, J., Brombacher, F. et al., Reactive oxygen species and 12/15-lipoxygenase contribute to the antiproliferative capacity of alternatively activated myeloid cells elicited during helminth infection. J. Immunol. 2005. 174: 6095-6104.
41. Manoli, T., Gretz, N., Grone, H. J., Kenzelmann, M., Eils, R. and Brors, B., Group testing for pathway analysis improves comparability of different microarray datasets. Bioinformatics 2006. 22: 2500-2506.